Definitions and incidence of cardiac syndrome X: review and analysis of clinical data

[1]  H. Meiselman,et al.  Microcirculatory Dysfunction in Cardiac Syndrome X: Role of Abnormal Blood Rheology , 2008, Microcirculation.

[2]  Lynda Evans,et al.  Cardiac rehabilitation for the treatment of women with chest pain and normal coronary arteries , 2008, Menopause.

[3]  T. Kılıç,et al.  Evaluation of post-stress left ventricular dysfunction and its relationship with perfusion abnormalities using gated SPECT in patients with cardiac syndrome X , 2008, Nuclear medicine communications.

[4]  U. Arslan,et al.  Plasma homocysteine level in cardiac syndrome X and its relation with duke treadmill score. , 2008, Saudi medical journal.

[5]  Roberto Cemin,et al.  Reduced coronary flow reserve and parasympathetic dysfunction in patients with cardiovascular syndrome X , 2008, Coronary artery disease.

[6]  Filippo Crea,et al.  Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. , 2008, Journal of the American College of Cardiology.

[7]  C. Cotrim,et al.  Exercise-induced intra-ventricular gradients as a frequent potential cause of myocardial ischemia in cardiac syndrome X patients , 2008, Cardiovascular ultrasound.

[8]  R. Zorc-Pleskovič,et al.  Inflammatory changes in small blood vessels in the endomyocardium of cardiac syndrome X in female patients with increased C-reactive protein. , 2008, Folia biologica.

[9]  Douglas L. Mann,et al.  Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 8th edition , 2018 .

[10]  E. Tatlı,et al.  Sympathetic Skin Response and RR Interval Variation in Patients With Cardiac Syndrome X , 2007, Angiology.

[11]  Jian‐Jun Li,et al.  Elevated circulating inflammatory markers in female patients with cardiac syndrome X. , 2007, Cytokine.

[12]  Y. Tavil,et al.  Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X , 2007, Coronary artery disease.

[13]  J. Kubica,et al.  Endothelial function in patients with chest pain and normal coronary angiograms. , 2007, Kardiologia polska.

[14]  M. Yıldız,et al.  Assessment of Arterial Distensibility in Patients With Cardiac Syndrome X , 2007, Angiology.

[15]  T. Wilczok,et al.  Transcriptional Activity of Genes Encoding Interferon γ (IFNγ) and its Receptor Assessed in Peripheral Blood Mononuclear Cells in Patients with Cardiac Syndrome X , 2007, Inflammation.

[16]  S. Saygi,et al.  Serum paraoxonase 1 activity and oxidative markers of LDL in patients with cardiac syndrome X , 2007, Acta cardiologica.

[17]  Filippo Crea,et al.  Noninvasive evaluation of flow reserve in the left anterior descending coronary artery in patients with cardiac syndrome X. , 2007, The American journal of cardiology.

[18]  Shing‐Jong Lin,et al.  Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X , 2007, Heart.

[19]  H. Çelik,et al.  Increased lymphocyte deoxyribonucleic acid damage in patients with cardiac syndrome X. , 2007, Mutation research.

[20]  B. Lewis,et al.  Endothelial cell dysfunction in women with cardiac syndrome X and MTHFR C677T mutation. , 2007, The Israel Medical Association journal : IMAJ.

[21]  Zhen-peng Zhang,et al.  Summary of 32 patients with cardiac syndrome X treated by TCM therapy of regulating qi relieving chest stuffiness and promoting blood circulation , 2007, Chinese journal of integrative medicine.

[22]  O. Erel,et al.  Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers , 2007, Coronary artery disease.

[23]  A. Wykrętowicz,et al.  Comparison of the exercise treadmill test and 24-hour ECG Holter monitoring in patients with syndrome X or coronary atherosclerosis. , 2007, Kardiologia polska.

[24]  Y. Tavil,et al.  Coronary blood flow in patients with cardiac syndrome X , 2007, Coronary artery disease.

[25]  F. Crea,et al.  Long-term follow-up of patients with cardiac syndrome X treated by spinal cord stimulation , 2007, Heart.

[26]  T. Wilczok,et al.  Gene expression of kinin receptors B1 and B2 in PBMC from patients with cardiac syndrome X , 2007, Scandinavian cardiovascular journal : SCJ.

[27]  G. Lanza,et al.  Cardiac syndrome X: a critical overview and future perspectives , 2005, Heart.

[28]  S. Saltissi,et al.  The effects of the angiotensin II receptor (type I) antagonist irbesartan in patients with cardiac syndrome X , 2005, Heart.

[29]  P. Camici.  Is the chest pain in cardiac syndrome X due to subendocardial ischaemia? , 2002, European heart journal.

[30]  王强,et al.  Summary of 32 Patients with Cardiac Syndrome X Treated by TCM Therapy of Regulating Qi Relieving Chest Stuffiness and Promoting Blood Circulation , 2007 .

[31]  L. Axel.  Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study. , 2007, European heart journal.

[32]  T. Wilczok,et al.  Transcriptional activity of genes encoding interferon gamma (IFNgamma) and its receptor assessed in peripheral blood mononuclear cells in patients with cardiac syndrome X. , 2007, Inflammation.

[33]  H. Miller,et al.  Circulating endothelial progenitor cells in patients with cardiac syndrome X , 2006, Heart.

[34]  M. Staal,et al.  Myocardial perfusion quantification in patients suspected of cardiac syndrome X with positive and negative exercise testing: A [13N]ammonia positron emission tomography study , 2006, Nuclear medicine communications.

[35]  M. Malek,et al.  Association of Helicobacter pylori infection with cardiac syndrome X. , 2006, Singapore medical journal.

[36]  W. Ferrell,et al.  Microvascular function, metabolic syndrome, and novel risk factor status in women with cardiac syndrome X. , 2006, The American journal of cardiology.

[37]  C. Nam,et al.  The Incidence of Gastro-Esophageal Disease for the Patients with Typical Chest Pain and a Normal Coronary Angiogram , 2006, The Korean journal of internal medicine.

[38]  U. Sechtem,et al.  Transient left ventricular dysfunction with apical ballooning (tako–tsubo cardiomyopathy) in Germany , 2006, Clinical Research in Cardiology.

[39]  J. Kaski,et al.  Cardiac syndrome X in women: the role of oestrogen deficiency , 2006, Heart.

[40]  H. Leu,et al.  Circulating mononuclear superoxide production and inflammatory markers for long-term prognosis in patients with cardiac syndrome X. , 2006, Free radical biology & medicine.

[41]  M. Katoh,et al.  Stress cardiomyopathy mimicking acute coronary syndrome: case presentation and review of the literature , 2006, Clinical Research in Cardiology.

[42]  Ş. Korkmaz,et al.  Increased aortic pulse and fractional pulse pressures in patients with cardiac syndrome X , 2006, Blood pressure.

[43]  M. Babaei.  Association of Helicobacter pylori infection with cardiac syndrome , 2006 .

[44]  C. R. Wilson,et al.  The metabolic syndrome and the heart--a considered opinion. , 2006, Clinical research in cardiology : official journal of the German Cardiac Society.

[45]  J. Sowiński,et al.  Myocardial perfusion SPECT with dipyridamole stress test in cardiac syndrome X , 2006, Nuklearmedizin.

[46]  Ş. Korkmaz,et al.  Mean Platelet Volume in the Patients with Cardiac Syndrome X , 2005, Journal of Thrombosis and Thrombolysis.

[47]  Y. On,et al.  Are low total serum antioxidant status and elevated levels of C-reactive protein and monocyte chemotactic protein-1 associated with cardiac syndrome X? , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[48]  J. Kaski,et al.  Brachial artery flow-mediated dilation and myocardial perfusion in patients with cardiac syndrome X. , 2005, The American journal of cardiology.

[49]  Hangyuan Guo,et al.  Status of intracellular and extracellular magnesium concentration in patients with cardiac syndrome X , 2005, Acta cardiologica.

[50]  F. Crea,et al.  Effect of spinal cord stimulation on spontaneous and stress-induced angina and 'ischemia-like' ST-segment depression in patients with cardiac syndrome X. , 2005, European heart journal.

[51]  H. Turhan,et al.  Increased Levels of Soluble Adhesion Molecules E-Selectin and P-Selectin in Patients with Cardiac Syndrome X , 2005, Angiology.

[52]  Abnormal cortical pain processing in patients with cardiac syndrome X. , 2005, European heart journal.

[53]  P. Pasqualetti,et al.  Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. , 2005, International journal of cardiology.

[54]  A. Palazzuoli,et al.  Structural and functional abnormality of systemic microvessels in cardiac syndrome X. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[55]  B. Gorenek,et al.  Regional distribution and extent of perfusion abnormalities, and the lung to heart uptake ratios during exercise thallium-201 SPECT imaging in patients with cardiac syndrome X. , 2005, The Canadian journal of cardiology.

[56]  F. Crea,et al.  Platelet reactivity in response to mental stress in syndrome X and in stable or unstable coronary artery disease. , 2005, Thrombosis research.

[57]  F. Creed,et al.  Distinct psychosocial differences between women with coronary heart disease and cardiac syndrome X. , 2004, European heart journal.

[58]  A. Altun,et al.  Decreased serum osteoprotegerin levels in patients with cardiac syndrome X , 2004, Journal of endocrinological investigation.

[59]  E. Picano,et al.  Effect of simvastatin on endothelial function in cardiac syndrome X patients. , 2004, The American journal of cardiology.

[60]  F. Crea,et al.  Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. , 2004, The American journal of cardiology.

[61]  R. Erbel,et al.  Identification of syndrome X using intravascular ultrasound imaging and Doppler flow mapping. , 2004, Chinese Medical Journal.

[62]  K. Kajinami,et al.  Myocardial glucose metabolism assessed by positron emission tomography and the histopathologic findings of microvessels in syndrome X. , 2004 .

[63]  C. Pizzi,et al.  Angiotensin-Converting Enzyme Inhibitors and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Cardiac Syndrome X: Role of Superoxide Dismutase Activity , 2004, Circulation.

[64]  Robert O. Bonow,et al.  Heart Disease: A Textbook of Cardiovascular Medicine. 7th Edition , 2004 .

[65]  B. Kieć-Wilk,et al.  Exercise tolerance and hyperinsulinemia in cardiac syndrome X. , 2004, Folia medica Cracoviensia.

[66]  Satake Osamichi,et al.  Myocardial glucose metabolism assessed by positron emission tomography and the histopathologic findings of microvessels in syndrome X. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[67]  G. Królczyk,et al.  Cardiac syndrome X--autonomic system disorders. , 2004, Folia medica Cracoviensia.

[68]  M. Eren,et al.  Aortic stiffness in patients with cardiac syndrome X , 2003, Acta cardiologica.

[69]  J. Kasprzak,et al.  Cardiological syndrome X. Non-invasive assessment of endothelial function and arterial compliance. , 2003, Kardiologia polska.

[70]  J. Kaski.  Overview of gender aspects of cardiac syndrome X. , 2002, Cardiovascular research.

[71]  A. Szczeklik,et al.  Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy , 2000, Heart.